Abstract
The first requirement in tackling this broad subject is a satisfactory definition of strategy. Since the subject concerns the war against gallstone disease, and since this book is an international undertaking, we thought it appropriate to consult the writings of a famous military strategist, Von Clausewitz. He states that ‘die Strategie ist der Gebrauch des Gefechts zum Zweck des Krieges’. This is translated as ‘strategy is the use of battles for the object of the war’. Thus, strategy consists of relating methods to a clearly defined object. We would define the object of the war against gallstone disease as being ‘to ensure that as many gallstone patients as possible are maintained free of gallstones in the long term’. In order to achieve this object, we have at present three non-surgical methods that we can use - a physical approach (fragmentation therapy or extracorporeal shock wave lithotripsy), a chemical approach (the use of chemical solvents, in particular methyl tert-butyl ether) and a physico-chemical approach (bile acid therapy using chenodeoxycholic acid (CDCA) and/or ursodeoxycholic acid UDCA)).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Ransohoff, D.F. (1985). Natural history of silent gallstones. In Paumgartner, G., Stiehl, A. and Gerok, W. (eds.) Enterohepatic Circulation of Bile Acids and Sterol Metabolism. pp. 277–84 (Lancaster: MTP Press)
Attili, A.F. (1986). Natural history and prevention. In Bateson, M. (ed.) Gallstone Disease and its Management, pp. 57–70. (Lancaster: MTP Press)
Paumgartner, G. (1988). In Northfield, T.C., Jazrawi, R. and Zentler-Munro, P.L. (eds.) Bile Acids in Health and Disease. Ch. 15. (Lancaster: MTP Press)
Thistle, J.L. (1988). In Northfield, T.C., Jazrawi, R. and Zentler-Munro, P.L. (eds.) Bile Acids in Health and Disease Ch. 14. (Lancaster: MTP Press)
Hospital in-patient enquiry, 1985. Series HB4 No. 27. DHSS Office of Population Censuses and Surveys. HMSO London, 1987
Pounder, R. (1981). Model of medical treatment for duodenal ulcer. Lancet, 1, 29–30
Hood, K. (1988). In Northfield, T.C., Jazrawi, R. and Zentler-Munro, P.L. (eds.) Bile Acids in Health and Disease. Ch. 11. (Lancaster: MTP Press)
Kupfer, R.M., Maudgal, D.P. and Northfield, T.C. (1982). Gallstone dissolution rate during chenic acid therapy. Effect of bedtime administration plus low cholesterol diet. Dig. Dis. Sci., 27, 1025–29
Maton, P.N., Iser, J.H., Reuben, A., Saxton, H.M., Murphy, G.M. and Dowling, R.H. (1982). The final outcome of CDCA-treatment in 125 patients with radiolucent gallstones: factors influencing efficacy, withdrawal, symptoms and side effects and postdissolution recurrence. Medicine, 61, 85–96
Ruppin, D.C. and Dowling, R.H. (1982). Is recurrence inevitable after gallstone dissolution by bile acid treatment? Lancet, 1, 181–5
Lanzini, A., Jazrawi, R.P. and Northfield, T.C. (1986). Gallstone recurrence after medical dissolution: an over-estimated threat? J. Hepatol, 3, 241–6
Northfield, T.C. and Jasrawi, R.P (1988). Patient selection for bile acid therapy. In Paumgartner, G., Stiehl, A. and Gerok, W. (eds) Bile Acids and the Liver, pp. 329–342, (Lancaster: MTP Press)
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Kluwer Academic Publishers
About this chapter
Cite this chapter
Northfield, T.C., Jazrawi, R.P. (1988). Overall Strategy. In: Northfield, T., Jazrawi, R., Zentler-Munro, P. (eds) Bile Acids in Health and Disease. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-1249-6_16
Download citation
DOI: https://doi.org/10.1007/978-94-009-1249-6_16
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-7054-6
Online ISBN: 978-94-009-1249-6
eBook Packages: Springer Book Archive